NH2-(dK)-SVT-(dR)-EDTGTYTC-OH

Product Name
NH2-(dK)-SVT-(dR)-EDTGTYTC-OH
Product Quantity
1g
Catalog Number
6093
Category
P4D Peptide
Sequence
NH2-(dK)-SVT-(dR)-EDTGTYTC-OH
Purity
>95%
Modifications
D-amino acids, specifically D-lysine (dK) and D-arginine (dR)
Product Description

Peptide P4D (NH₂-(dK)-SVT-(dR)-EDTGTYTC-CONH₂) is a synthetically engineered peptide designed for targeted therapeutic applications, particularly in immunosuppression and autoimmune disease management. Its structure incorporates D-amino acids, specifically D-lysine (dK) and D-arginine (dR), which enhance its stability against enzymatic degradation, thereby prolonging its bioavailability in biological systems.

Functionality and Biological Importance:

Peptide P4D functions by mimicking specific protein surface epitopes, allowing it to interfere with critical protein-protein interactions involved in immune responses. This mimicry enables P4D to inhibit interactions such as the CD4-MHC class II binding, which is pivotal in the activation of CD4⁺ T cells. By disrupting this interaction, P4D effectively reduces T cell proliferation, thereby exhibiting significant immunosuppressive properties. Studies have demonstrated that similar peptides can inhibit CD4⁺ T cell activation, leading to a decrease in immune response intensity.

Applications in Research:

Peptide P4D’s immunosuppressive capabilities make it a valuable tool in various research domains:
  • Autoimmune Disease Models: In experimental autoimmune encephalomyelitis (EAE), a murine model for multiple sclerosis, peptides with analogous structures to P4D have been shown to reduce disease severity. This suggests potential applications in studying therapeutic interventions for autoimmune conditions.
  • Transplantation Studies: The peptide’s ability to prolong skin allograft survival in mice indicates its utility in transplantation research, offering insights into novel strategies for graft acceptance and longevity.
  • Graft-versus-Host Disease (GVHD) Research: Administration of similar peptides has resulted in improved survival rates in murine models of GVHD, highlighting their potential in developing treatments to mitigate this condition.

The incorporation of D-amino acids into P4D’s structure not only enhances its resistance to proteolytic degradation but also ensures its functional integrity in vivo. This structural stability is crucial for maintaining the peptide’s therapeutic efficacy over extended periods.

Peptide P4D represents a promising agent in immunological research, offering a stable and effective means to modulate immune responses. Its applications span from elucidating mechanisms of autoimmune diseases to developing innovative strategies for transplantation and GVHD management.

Scientific Background

NH2-(dK)-SVT-(dR)-EDTGTYTC-OH is a 8-residue synthetic peptide with the sequence Glu-Asp-Thr-Gly-Thr-Tyr-Thr-Cys. C-terminal amidation removes the terminal carboxylate charge. The sequence contains 1 cysteine residue, providing potential thiol/disulfide chemistry when the thiol is available. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence.

Research Applications
  • thiol-selective conjugation or immobilization studies
  • LC-MS/HPLC analytical method development
  • sequence-specific assay controls
Experimental Notes

Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions.

  • 1 Units in Stock
Ask a Question

$2,000.00

Add to Cart: